Pramara Promotions Limited – Preferential Issue Overview

Announcement Date: 21 April 2026
Board Meeting: 21 April 2026 (19:00 – 20:30)
AGM/E​GM: 21 May 2026

Key Transaction Details

• Securities Offered: Equity Shares and Convertible Warrants
• Total Units: 4,860,000
• Issue Price: INR 365 per share
• Total Funds to be Raised: INR 1,773,900,000
• Number of Investors: 123 (names to be disclosed post‑board meeting)
• Paid‑up Capital Increase:
  • Pre‑issue: INR 139,441,680 (13,944,168 shares)
  • Post‑issue: INR 190,991,680 (19,099,168 shares)

Strategic Rationale

• Capital for Growth: The infusion is intended to fund expansion, product development, and potential acquisitions.
• Strengthened Balance Sheet: Enhances liquidity and reduces reliance on debt financing.
• Investor Base Expansion: Broadening the shareholder base with 123 investors may improve market perception.

Regulatory & Compliance

• The announcement complies with SEBI Circular dated 9 September 2015.
• Prior intimation of the board meeting was submitted to the NSE on 6 April 2026.
• No record/book‑closure date has been fixed yet; the company will announce it later.

Risks & Considerations

• Dilution: Existing shareholders will see a reduction in ownership percentage.
• Conversion Uncertainty: The date and terms of warrant conversion are not yet defined, creating potential future dilution and earnings impact.
• Market Reception: The success of the issue depends on investor appetite at the set price of INR 365.

Opportunities

• Growth Funding: Access to fresh capital can accelerate strategic initiatives and improve competitive positioning.
• Potential Upside: If the raised funds are deployed effectively, earnings per share could improve in the medium term.

Next Steps

1. AGM on 21 May 2026 – Final approval of the issue and disclosure of subscription results.
2. Post‑AGM Disclosure – Detailed allocation of shares/warrants and conversion schedule.
3. Monitoring – Track the company’s use of proceeds and any subsequent announcements regarding conversion terms.

Investors should weigh the dilution impact against the growth potential of the capital raise and stay alert for further updates from the AGM and board disclosures.